105.18USD-1.41%Mkt Cap: 22.98B USDP/E: —Last update: 2026-06-01
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap22.98B USD
Enterprise Value22.69B USD
Revenue (TTM)819.56M USD
Gross Profit483.49M USD
Net Income (TTM)-1.28B USD
Revenue/Share3.947 USD
Last Price105.18 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.7K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)264.60
PEG1.09
EV/EBITDA-23.91
EV/Revenue27.69
P/S28.27
P/B32.84
EPS (TTM)-5.76
EPS (Forward)0.40
52W Range
67.8126% of range212.75
52W High212.75 USD
52W Low67.81 USD
Profitability
Gross Margin79.73%
Oper. Margin-65.46%
EBITDA Margin-115.80%
Profit Margin-210.54%
ROE-172.78%
ROA-56.38%
Growth
Revenue Growth229.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-935.01M USD
CapEx (TTM)32.56M USD
FCF Margin-73.97%
FCF Yield-2.64%
Net Debt-481.05M USD
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity0.73
Current Ratio4.47
Quick Ratio3.88
Book Value/Sh3.255 USD
Cash/Share5.645 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMar 3, 2011
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)200.00 USD
Target Range140.00 USD – 243.00 USD
# Analysts21
Ownership
Shares Out.216.75M
Float198.27M
Insiders0.53%
Institutions105.25%
Short Interest
Short Ratio5.2d
Short % Float9.16%
Short % Out.8.12%
Shares Short17.61M
Short (prev mo.)13.86M
Technical
SMA 50135.23 (-22.2%)
SMA 200155.95 (-32.6%)
Beta0.89
S&P 52W Chg27.94%
Avg Vol (30d)3.23M
Avg Vol (10d)3.06M
Technical Indicators
RSI (14)36.2
MACD-8.1485
MACD Signal-8.8064
MACD Hist.+0.6579
BB Upper139.45 USD
BB Middle114.45 USD
BB Lower89.44 USD
BB Width43.70%
ATR (14)6.086 USD
Vol Ratio (20d)0.52x